BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34271426)

  • 1. Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium.
    Dubon Garcia A; Devlieger R; Redekop K; Vandeweyer K; Verlohren S; Poon LC
    Pregnancy Hypertens; 2021 Aug; 25():219-224. PubMed ID: 34271426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study.
    Nzelu D; Palmer T; Stott D; Pandya P; Napolitano R; Casagrandi D; Ammari C; Hillman S
    BJOG; 2024 Jan; 131(2):222-230. PubMed ID: 37431533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 22(5):1-118. PubMed ID: 37772268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care.
    Park F; Deeming S; Bennett N; Hyett J
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):688-697. PubMed ID: 32851709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
    Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
    Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women.
    Mone F; O'Mahony JF; Tyrrell E; Mulcahy C; McParland P; Breathnach F; Morrison JJ; Higgins J; Daly S; Cotter A; Hunter A; Dicker P; Tully E; Malone FD; Normand C; McAuliffe FM
    Hypertension; 2018 Dec; 72(6):1391-1396. PubMed ID: 30571234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings.
    Zakiyah N; Tuytten R; Baker PN; Kenny LC; Postma MJ; van Asselt ADI;
    PLoS One; 2022; 17(4):e0267313. PubMed ID: 35446907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland.
    Mewes JC; Lindenberg M; Vrijhoef HJM
    PLoS One; 2022; 17(6):e0270490. PubMed ID: 35763507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands.
    Beernink RHJ; Scherjon SA; Cremers TIFH; van Asselt ADI
    J Reprod Immunol; 2023 Dec; 160():104141. PubMed ID: 37708725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis.
    Waites BT; Walker AR; Skeith AA; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4123-4129. PubMed ID: 33179564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.
    Park FJ; Leung CH; Poon LC; Williams PF; Rothwell SJ; Hyett JA
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):532-9. PubMed ID: 23919594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study.
    Brunelli E; Seidenari A; Germano C; Prefumo F; Cavoretto P; Di Martino D; Masturzo B; Morano D; Rizzo N; Farina A
    BJOG; 2020 Sep; 127(10):1210-1215. PubMed ID: 32275798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm.
    Mosimann B; Pfiffner C; Amylidi-Mohr S; Risch L; Surbek D; Raio L
    Swiss Med Wkly; 2017; 147():w14498. PubMed ID: 28871576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.